Measuring collateral ventilation using Chartis® to select patients with severe emphysema for endobronchial valve treatment: conscious sedation versus general anesthesia
Completed
- Conditions
- Lung disease10038716Emphysema
- Registration Number
- NL-OMON46522
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
-Patient is scheduled for a bronchoscopic lung volume treatment using one-way valves
-Patient has provided signed informed consent.
Exclusion Criteria
1) FEV1 < 20%
2) RV/TLC>70%
3) pCO2 >6.5
4) RVSP>40mmHg
5) 6MWT<200m
6) Known intolerance to Lidocaine
7) Any other medical reason/condition that warrants a short procedure ( physician judgement )
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary Objective:<br /><br>1. To compare the duration of Chartis measurement in patients undergoing<br /><br>conscious sedation versus general anesthesia.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary Objectives:<br /><br><br /><br>2. The failure rate of the Chartis collateral ventilation measurement under<br /><br>general anesthesia versus conscious sedation<br /><br><br /><br>3. To investigate qualitative assessment feasibility for the physician in<br /><br>patients undergoing conscious sedation or general anesthesia.<br /><br><br /><br>4. To investigate the influence of severity of disease in patients undergoing<br /><br>conscious sedation or general anesthesia.<br /><br><br /><br>5. To investigate outcome difference in collateral ventilation status in<br /><br>patients undergoing conscious sedation versus general anesthesia</p><br>